Bayer AG, headquartered in Leverkusen, Germany, opened a 70,000-square-foot expansion at its Myerstown, Pennsylvania, facility after a $44 million investment. This modern facility strengthens Bayer’s commitment to delivering reliable self-care products across North America. The company also completed its first Cell Therapy Launch Facility in Berkeley, California, further supporting its focus on the region.

The Aspirin production line at the new Myerstown facility.

The Myerstown ribbon-cutting ceremony brought together Bayer leaders, employees, local officials, and Lebanon County community members. With a history spanning over 75 years, the Myerstown site is now the largest in Bayer’s global Consumer Health network, producing brands like Bayer® Aspirin, Aleve®, Claritin®, One A Day®, Alka-Seltzer Plus®, and Midol®.

“Our trusted brands have been helping people live healthier lives for generations. The Myerstown annex will enable us to bring science-backed products to market with more speed and reliability than ever before,” said Dave Tomasi, President of Bayer’s Consumer Health division in North America.

The expanded facility incorporates advanced technology, featuring eight new packaging lines and automated logistics systems to enhance production efficiency. These improvements enable Bayer to better meet consumer demands while upholding high-quality standards in self-care solutions.

Bayer’s investment extends beyond infrastructure to include its workforce and the Myerstown community. The company is offering digital training to employees to navigate modern manufacturing technologies. Additionally, Bayer plans to host local high school educators for facility tours, sharing knowledge to inspire students.

“We recognize that the key to sustainable growth lies in our people. That’s why we will enable our workforce with the skills needed to adapt to new technologies so they can excel in their careers,” said Divakar Amin, Vice President & Site Manager of Myerstown. “We are proud to contribute to the local economy and foster a vibrant workforce made up of many Myerstown locals.”

Bayer’s dedication to science-driven health solutions aligns with its mission to improve well-being. “Our commitment to credible science and consumer advocacy drives our mission Health for all, Hunger for none,” said Michael Sullivan, Senior Vice President of Product Supply for Bayer’s Consumer Health division in North America. The Myerstown expansion enhances Bayer’s capacity to deliver effective, trusted products, supporting healthier lives for consumers throughout the region.